Making Intelligent Connections Possible: Better Data

By Jacinta Rodrigues, Director, Clinical Data Management, IQVIA Connected Devices

As clinical trial sponsors face increasing pressure to deliver new treatments to market faster, connected digital medical devices are taking on a larger and more critical role. Creating a smart data strategy, with streamlined data collection and compliant reporting, requires strategic solutions that are automated, flexible, and fit-for-purpose.

With the volume and complexity of the data collected in modern clinical trials, a proliferation of connected devices has flooded the market with new and novel technologies. Selecting a device that fits both a trial and a data strategy can present a challenge for sponsors.  In recent times, a significant number of trials have transitioned from traditional site-based, centralized activities to patient-centric or decentralized trials and hybrid trials, which blend in-person trial design with remote technologies in order to ease the burden for patients. Using connected devices to facilitate patient-centric or hybrid trials changes a data strategy significantly.

IQVIA’s Connected Devices digital platform is designed to be fully device-agnostic. This allows integration of data from any device via the ingest modalities like USB, cellular, Bluetooth, cloud-based API, or Wi-Fi-enabled technologies. This data ecosystem facilitates automated data uptake from a range of devices and locations, capturing and reviewing data while engaging in real-time data cleaning, harmonization, and standardization.